PH12014502086B1 - Vaccine against rsv - Google Patents

Vaccine against rsv

Info

Publication number
PH12014502086B1
PH12014502086B1 PH12014502086A PH12014502086A PH12014502086B1 PH 12014502086 B1 PH12014502086 B1 PH 12014502086B1 PH 12014502086 A PH12014502086 A PH 12014502086A PH 12014502086 A PH12014502086 A PH 12014502086A PH 12014502086 B1 PH12014502086 B1 PH 12014502086B1
Authority
PH
Philippines
Prior art keywords
vaccine against
rsv
against rsv
serotype
protein
Prior art date
Application number
PH12014502086A
Other versions
PH12014502086A1 (en
Inventor
Katarina Radosevic
Jer“Me H H V Custers
Jort Vellinga
Myra N Widjojoatmodjo
Original Assignee
Janssen Vaccines And Prevention B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2013/055943 external-priority patent/WO2013139916A1/en
Application filed by Janssen Vaccines And Prevention B V filed Critical Janssen Vaccines And Prevention B V
Publication of PH12014502086B1 publication Critical patent/PH12014502086B1/en
Publication of PH12014502086A1 publication Critical patent/PH12014502086A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Abstract

The invention provides a vaccine against respiratory syncytial virus (RSV), comprising a recombinant human adenovirus of serotype that comprises nucleic acid encoding a RSV F protein or immunologically active part thereof.
PH12014502086A 2012-03-22 2014-09-22 Vaccine against rsv PH12014502086A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261614429P 2012-03-22 2012-03-22
EP12160682 2012-03-22
PCT/EP2013/055943 WO2013139916A1 (en) 2012-03-22 2013-03-21 Vaccine against rsv

Publications (2)

Publication Number Publication Date
PH12014502086B1 true PH12014502086B1 (en) 2014-11-24
PH12014502086A1 PH12014502086A1 (en) 2014-11-24

Family

ID=52580709

Family Applications (2)

Application Number Title Priority Date Filing Date
PH12014502013A PH12014502013A1 (en) 2012-03-22 2014-09-09 Vaccine against rsv
PH12014502086A PH12014502086A1 (en) 2012-03-22 2014-09-22 Vaccine against rsv

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PH12014502013A PH12014502013A1 (en) 2012-03-22 2014-09-09 Vaccine against rsv

Country Status (8)

Country Link
KR (1) KR20190107182A (en)
BR (1) BR112014023195B1 (en)
CL (2) CL2014002499A1 (en)
HK (2) HK1206272A1 (en)
IL (2) IL234758A (en)
MX (2) MX352908B (en)
PH (2) PH12014502013A1 (en)
ZA (2) ZA201406890B (en)

Also Published As

Publication number Publication date
PH12014502013B1 (en) 2014-11-24
CL2014002499A1 (en) 2015-01-09
BR112014023195B1 (en) 2021-05-04
ZA201406892B (en) 2015-12-23
MX2014011341A (en) 2015-05-11
ZA201406890B (en) 2015-12-23
KR20190107182A (en) 2019-09-18
MX351482B (en) 2017-10-03
CL2014002500A1 (en) 2015-01-16
IL234760A (en) 2016-07-31
MX352908B (en) 2017-12-13
HK1206274A1 (en) 2016-01-08
IL234758A (en) 2016-07-31
MX2014011340A (en) 2015-05-11
PH12014502013A1 (en) 2014-11-24
PH12014502086A1 (en) 2014-11-24
HK1206272A1 (en) 2016-01-08

Similar Documents

Publication Publication Date Title
MY169331A (en) Vaccine against rsv
CY1121600T1 (en) STABILIZED SOLUTIONS RSV F ADHESION POLYPEPTIDES
PH12018500856A1 (en) Respiratory syncytial virus vaccine
CY1117673T1 (en) Recombinant RSV antigens
EP3551193A4 (en) Respiratory virus nucleic acid vaccines
GEP20217260B (en) Antibody neutralizing human respiratory syncytial virus
EA201890527A1 (en) THERAPEUTIC VACCINES AGAINST HPV18
WO2012024621A3 (en) Synthetic nanocarrier vaccines comprising peptides obtained or derived from human influenza a virus hemagglutinin
MX2021001053A (en) Influenza virus vaccines and uses thereof.
WO2016086088A3 (en) Wound healing through sirt1 overexpression
HK1205459A1 (en) Recombinant modified vaccinia virus ankara (mva) respiratory syncytial virus (rsv) vaccine (mva)(rsv)
WO2013106834A3 (en) Immunogenic wt-1 peptides and methods of use thereof
WO2006115843A3 (en) Nipah virus vaccines
WO2012021730A3 (en) Respiratory syncytial virus (rsv) vaccine
WO2013006569A3 (en) Herpes virus vaccine and methods of use
MX2018005462A (en) Chimeric RSV, Immunogenic Compositions, and Methods of Use.
WO2012058493A3 (en) Recombinant hemagglutinin protein of influenza virus and vaccine containing the same
WO2015041924A8 (en) Recombinant respiratory syncytial virus (rsv) and vaccines
PH12014502086B1 (en) Vaccine against rsv
EP2879705A4 (en) PEPTIDE VACCINES BASED ON THE EGFRvIII SEQUENCE FOR THE TREATMENT OF TUMORS
ZA201500606B (en) Recombinant modified vaccinia virus ankara (mva) respiratory syncytial virus (rsv) vaccine
DK3436053T3 (en) FORMULATIONS COMPRISING RECOMBINANT ACID ALPHA-GLUCOSIDASE
MA39900A (en) Nucleic acid vaccines
MX2012006516A (en) Vaccine adjuvant composition based on ursolic acid.